GEN News Highlights: Nov 11, 2009

Persistent Upgrades LIMS Application to Include Tissue Data for UC-Davis

(Page 1 of 1)

    Persistent Systems has partnered with the University of California, Davis to develop a data-management system for preclinical scientists. The tool called caELMIR 2 (electronic laboratory management information resource) will be based on the company’s caBIG® LIMS application.

    The updated version of caELMIR is integrated with caTissue, caBIG’s tissue-bank repository tool, for biospecimen inventory, tracking, and basic annotation. This caELMIR-caTissue integration reportedly enables scientists to store and access both preclinical data and tissue repository data, allowing them to find and procure tissues from previous experiments.

    Traditionally scientists have had to use specially designed databases to store the various data sets. The database was ineffective, however, when data collected did not fit in it. Additionally, such silo systems had synchronization issues, creating incomprehensible data.

    caELMIR 2 reportedly helps address these issues. It allows investigators to manage every aspect of preclinical studies, including tracking experimental tissue data and utilization, managing experiments, and handling the multitude of data types recorded for given experiments.

    The integration fully re-uses existing common data elements (CDE), ensuring semantic interoperability and retaining existing metadata information of all re-used CDEs to ensure seamless data exchange over the caGrid.

     


Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll